Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4762 results found.

Example of search result explained

Acyclovir sodique injectable

Covered
  • Active ingredient(s):
    acyclovir sodium
  • Manufactured by:
    Sterimax Inc. (Sterimax)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 50 mg/mL (10 mL) DIN : 2456524
    • Intravenous Perfusion Solution 50 mg/mL (20 mL) DIN : 99106293

Acyclovir Sodium Injection

Covered
  • Active ingredient(s):
    acyclovir sodium
  • Manufactured by:
    Auro Pharma Inc. (AuroPharma)
  • Strength and dosage form:
    • Intravenous Perfusion Solution 50 mg/mL (10 mL) DIN : 2494558
    • Intravenous Perfusion Solution 50 mg/mL (20 mL) DIN : 99113861

Hyrimoz (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,2 mL) DIN : 2542315
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542323
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542358
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 2505258
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492164

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533480
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473100

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2533472
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2473097

Hyrimoz (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2542331
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2542366
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 2492156

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523949
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2523965

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523957

Yuflyma (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523760
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2535076

Yuflyma (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 2523779
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 2535084
Page 10 of 477

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.